FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
$0.82 per share
Est. EPS $0.11 · Revenue $872.18M · 9 analysts
$0.82 per share
Est. EPS $1.10 · Revenue $1.12B · 9 analysts
EPS $-0.12 · Revenue $791.40M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $3.5B | -18.3% | +14.3% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-2.2B | -758.7% | +33.7% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +37.0% | -0.4% | +21.4% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -54.4% | -452.9% | -29.3% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -64.6% | -906.6% | +42.0% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-176.5M | -129.3% | +151.1% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -5.1% | -135.8% | +144.7% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 202.7% | +160.2% | +2.3% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.32x | -19.6% | +54.5% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $9.7B | -16.9% | -2.9% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -17.88 vs 2.95 | -706.0% | -1.48 vs 0.11 | -1430.0% |
| Revenue Surprise | $3.5B vs $3.9B | -11.8% | $867.1M vs $872.2M | -0.6% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | BRONDEAU PIERRE R | director, officer: Chairman, CEO and President | Common Stock | A | 44 | — |
| Jul 16, 2026 | CORDEIRO EDUARDO E | director | Common Stock | A | 131 | — |
| Jul 16, 2026 | DAVIDSON CAROL ANTHONY | director | Common Stock | A | 83 | — |
| Jul 16, 2026 | Fortmann Kathy Lynn | director | Common Stock | A | 101 | — |
| Jul 16, 2026 | Johnson KLynne | director | Common Stock | A | 184 | — |
Operator: Ladies and gentlemen, thank you for joining us, and welcome to the First Quarter 2026 Earnings Call for FMC Corporation. This event is being recorded. I will now hand the conference over to Mr. Curt Brooks, Director of Investor Relations for FMC Corporation. Please go ahead. Curt Brooks: Good morning, and welcome to FMC Corporation's 2026 First Quarter Earnings Call. Today's prepared remarks will be provided by Pierre Brondeau, Chairman, Chief Executive Officer and President; and Andrew Sandifer, Executive Vice President and Chief Financial Officer. After prepared comments, we will take questions. Our earnings release and today's slide presentation are available on the FMC Investor Relations website, and the prepared remarks from today's discussion will be made available after the call. Let me remind you that today's presentation and discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our earnings release and in our filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's understanding. Actual results may vary based on these risks and uncertainties. Today's discussion and the supporting materials will include references to adjusted EPS, adjusted EBITDA, free cash flow, organic revenue growth and revenue, excluding India, all of which are non-GAAP financial measures. Please note that as used in today's discussion, CTPR means Chlorantraniliprole, earnings means adjusted earnings, EBITDA means adjusted EBITDA and sales refers to sales excluding India. A reconciliation and definition of these terms as well as other non-GAAP financial terms to which we may refer during today's conference call are provided on our website. With that, I will now turn the call over to Pierre. Pierre Brondeau: Thank you, Curt, and good morning, everyone. During the first quarter, we delivered results that exceeded the midpoint of our guidance range. In addition, we made good progress on our 2026 operational priorities, which are listed on Slide 3. These are strengthening the balance sheet through targeted debt reduction of approximately $1 billion, improving the competitiveness of our core portfolio, managing the post-patent transition for Rynaxypyr and supporting sales growth of new active ingredients, including Isoflex active, fluindapyr and Dodhylex active. I will start by providing an update on the progress of these 4 operational priorities, beginning with the debt reduction. We are continuing to target approximately $1 billion of debt paydown during 2026. The sale of our India commercial business continues to progress very well. We are in late stages with several potential buyers and expect to sign a definitive agreement in May. In addition, we are in advanced discussions with multiple potential partners regarding licensing of one of our new active …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Pierre R. Brondeau | President, CEO & Non-Executive Chairman of the Board | USD 3,407,052 | — | 1958 | Active |
Andrew D. Sandifer | Executive Vice President & Chief Financial Officer | USD 1,581,180 | Male | 1970 | Active |
Jacqueline D. Scanlan | Executive VP & Chief Human Resources Officer | USD 1,019,172 | Female | 1973 | Active |
Thaisa Hugenneyer | Chief Sustainability Officer & Executive Vice President of Integrated Supply Chain | USD 906,542 | Female | 1980 | Active |
Vsevolod Rostovtsev | Executive Vice President & Chief Technology Officer | USD 670,315 | Male | 1975 | Active |
Shahid Saleem | Director & Head of Business Sustainability and Strategic Initiatives in Asia Pacific (APAC) | — | Male | — | Active |
Brian Angeli | Executive Vice President & President of North America | — | Male | 1977 | Active |
Curt Brooks | Director of Investor Relations | — | Male | — | Active |
Sara Velazquez Ponessa | Executive Vice President, General Counsel & Corporate Secretary | — | Female | 1972 | Active |
FMC NYSE: FMC reported second-quarter revenue of $841 million excluding India, below the low end of its guidance range, as cautious customer purchasing, unfavorable weather, low insect pressure and pricing pressure weighed on demand. However, adjusted EBITDA of $153 million exceeded the high end of management's guidance by 2%, aided by cost discipline and favorable quarter-specific items.
FMC Corporation (FMC) Q2 2026 Earnings Call Transcript
FMC reported second quarter earnings that missed revenue expectations. Management also guided to a lower revenue and earnings target for the year.
FMC's Q2 earnings beat estimates as cost gains offset weaker pricing and volumes. Revenues declined and 2026 sales guidance was cut.
FMC (FMC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.69 per share a year ago.
